Metacrine

Developer of protein sensitizers for insulin in type 2 diabetes and modulators for metabolic diseases

placeSan Diego, California, United States calendar_todayFounded 2015 groups32 employees language metacrine.com

Registered entities

Investor mix

17 investors on record; lead investors include Arch Venture Partners, EcoR1, Polaris Partners, VenBio; 1 has since exited.

Investor typeCountShare
Venture capital847%
Private equity212%
Bank & private debt212%
Other / undisclosed529%
Coming soon